Taoyuan, Taiwan

Chih-Hao Hung

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chang Gung University. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chih-Hao Hung. Retrieved from https://idiyas.com/inventor/chih-hao-hung-l2riop3w

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Chih-Hao Hung

Introduction

Chih-Hao Hung is a notable inventor based in Tao-Yuan, Taiwan. He has made significant contributions to the field of biochemistry, particularly in the development of pharmaceutical compounds. His work focuses on the design and synthesis of novel compounds that can serve as therapeutic agents.

Latest Patents

Chih-Hao Hung holds a patent for "FPR1 antagonist derivatives and use thereof." This patent describes a dipeptide derivative that acts as a formyl peptide receptor 1 (FPR1) antagonist. The dipeptide derivative is represented by a specific formula, which highlights its potential applications in medical treatments.

Career Highlights

Chih-Hao Hung is affiliated with Chang Gung University, where he engages in research and development activities. His academic background and research expertise have positioned him as a key figure in his field. He has dedicated his career to advancing knowledge and innovation in biochemistry.

Collaborations

Chih-Hao Hung has collaborated with esteemed colleagues such as Tsong-Long Hwang and Pei-Wen Hsieh. These collaborations have fostered a productive research environment, leading to advancements in their shared areas of interest.

Conclusion

Chih-Hao Hung's contributions to the field of biochemistry, particularly through his patent on FPR1 antagonist derivatives, underscore his role as an innovative inventor. His work continues to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…